Who are the Associates? The Hadassah Associates connect and activate men to improve ‚Äčworld health and to keep Israel strong. Through stimulating educational forums, health and well-being activities and enjoyable fundraising events, the Hadassah Associates build community in Israel and the US to advance medical research, healing, and education.

Our Associates are change makers who are putting their values into action. They are improving patients’ chances of survival through their support of groundbreaking research at Hadassah Medical Organization in Israel.

Men's Health Initiative

Associates have raised millions of dollars for medical research and patient care, including $2 million in funding for stem cell research at Hadassah Medical Organization in Israel. Dedicated to promoting better health, our Associates have launched a national Men’s Health Initiative to create awareness of health issues affecting men, such as Prostate Cancer, Lung Cancer and Cardiovascular Disease.


Become an Associate

Join our fellowship of over 33,000 men who support Hadassah’s lifesaving work. Support our practical approach to Zionism—making lives better here, in Israel and around the world.


Men's Health Initiative

The Associates' Men's Health Initiative allows Associates around the country to impact the groundbreaking medical advances happening every day at Hadassah Medical Organization (HMO) -- advances that will affect men's lives around the world. Read about these deadly diseases and HMO's cutting edge research.

Prostate Cancer

Prostate cancer can only be cured if diagnosed early, while the tumor is confined to the prostate gland. It is second only to lung cancer as a cause of death in American men. One in six men will be diagnosed with prostate cancer; one in 36 will die from the disease.

A patient was referred to HMO, although his physician said he was beyond medical help: his prostate cancer had spread to his pelvic lymph nodes. His prostate-specific antigen level (PSA), normally less than 4, was 273. The oncology team combined high-dose radiation and limited-duration hormonal treatment. Three years later, the patient is active and healthy, his sexual function has returned, and his PSA is less than 1.

Lung Cancer

The survival rate for lung cancer is only 20 percent after five years. HMO's Sharett Institute of Oncology is a referral center for cancer patients from all over the world.

HMO researchers recently discovered a compound that has successfully shrunk lung cell tumors by 50 percent on cell samples and laboratory mice. When the compound was used in conjunction with radiation therapy and chemotherapy, the pace of cancerous cell growth was reduced by about 90 percent. Theses are first steps in what may become a treatment or cure for lung cancer.


Heart disease kills one in four American men. Hadassah Medical Organization (HMO) is committed to preventing, diagnosing, treating, and continuing the research that could one day eradicate heart disease.

At Hadassah Medical Organization CARTO 3, a state-of-the-art 3D heart imaging system developed in Israel, maps the electrical circuitry of a patient's heart during ablation (removal of unwanted tissue) while minimizing X-ray exposure. Hadassah was among the first in the world to apply this technology.


Contact Us

40 Wall Street

New York, NY 10005

E: support@hadassah.org

P: (888) 303-3640

Membership Questions

E: membership@hadassah.org

P: (800) 664-5646

Donation Questions

E: donorservices@hadassah.org

P: (800) 928-0685

Mission Department

E: missions@hadassah.org

P: (800) 237-1517

Show More